nejm semaglutide ckd ➡️ The TOM of this month goes to the FLOW trial, showing the FLOWing Benefits of in People with Type 2 Diabetes and published @ nejm. #VA from the @nephjc group Kidney Outcomes With Glucagon-Like Peptide-1
Description
OSA affects an estimated 936 million people worldwide and is often linked to obesity and cardiometabolic risks.

#health #fitness #medicine #telemedicine #weightloss #healthylifestyle
Stefano 2026 Read by 431 Endogenous Morphine, Dopamine, GLP-1, and Nitric Oxide Signaling in Human Physiology: Implications for MindBody and Complementary Medicine in Current Research in Complementary & Alternative Medicine

GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro are gaining attention for their role in managing type 2 diabetes and supporting weight loss.

plantarum, L
